HIV Policy & Advocacy
Homeless People Have Higher Rates of HIV, Hepatitis C, and TB
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 24 August 2012 00:00
- Written by Liz Highleyman
Rates of HIV, hepatitis C, and tuberculosis (TB) vary considerably among homeless populations, but are significantly higher overall than those of people with stable housing, according to a study published in the August 20, 2012, advance online edition of Lancet Infectious Diseases.
Surveys Ask Gay Men about Sex, HIV+ People about Police, and Drugs Users about Harm Reduction
- Details
- Category: Gay & Bisexual Men/MSM
- Published on Tuesday, 21 August 2012 00:00
- Written by Liz Highleyman
Three new surveys are seeking participation, one looking at sexual risk behavior among gay and bisexual men, the second evaluating gay/lesbian/bisexual/transgender (LGBT) and HIV positive people's interactions with police, courts, and prisons, and the third assessing harm reduction practices among non-injecting drug users. 
AIDS 2012: Aspirin Dampens Immune Activation in HIV+ People on ART
- Details
- Category: Inflammation & Immune Activation
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
Taking a daily aspirin reduces immune activation and activity of platelets -- the cells responsible for blood clotting -- which may help counteract the increased risk of cardiovascular problems among people with HIV taking antiretroviral therapy (ART), researchers reported at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC. 
AIDS 2012: Studies Shed Light on Inflammation and Immune Activation in People with HIV
- Details
- Category: Inflammation & Immune Activation
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
HIV and aging was a major medical themes at the recent XIX International AIDS Conference (AIDS 2012) in Washington, DC. A growing body of evidence indicates that inflammation and excessive immune activation contribute to cardiovascular disease and other non-AIDS conditions in people with HIV as they live to older ages, despite viral suppression on antiretroviral therapy (ART). Several studies presented at the conference looked at the causes and consequences of inflammation in this population. 
AIDS 2012: HPTN 052 Continues to Show Clinical Benefits of Earlier Antiretroviral Therapy
- Details
- Category: When to Start ART?
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
The HPTN 052 trial, best known for showing that early antiretroviral therapy (ART) can dramatically reduce the risk of HIV transmission within serodiscordant couples, also found that early treatment reduces the risk of clinical events and death, though the benefit was largely driven by extrapulmonary tuberculosis, researchers reported recently at the XIX International AIDS Conference (AIDS 2012) in Washington, DC.
More Articles...
- AIDS 2012: Expanded Access to HIV Treatment Lowered AIDS Deaths Worldwide
- AIDS 2012: French Cohort Treated during Primary Infection Appears to Control HIV without ART
- AIDS 2012: HDAC Vorinostat Disrupts HIV Latency in Patients' CD4 Cells
- AIDS 2012: HIV PrEP: Toxic Lifelong Therapy or Effective Niche Prevention? [VIDEO]
Web Design and Development by